ArticleBlood cancer journal2024
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- HLH-like syndromes associate with increased risk of death and CD19- relapse after CAR T in pediatric B-ALL.Blood advances · 2026Observational
- Hemophagocytic lymphohistiocytosis in critically ill patients: A guide for clinicians.World journal of critical care medicine · 2026Review
- Article
- CD19-targeting CAR T cell therapy in five patients with systemic sclerosis unsuitable for autologous stem cell transplantation.EULAR rheumatology open · 2026Article
- The Conflicting Role of Myeloid Cells in CAR T-Cell Therapy.Cancer research · 2026Review
- Article
- Pharmacokinetics of CAR T cells in multiple myeloma - the good, the bad, and the ugly.Leukemia · 2026Review
- Redesigning CAR therapy to tackle immune effector cell-associated hematotoxicity.Annals of hematology · 2026Review
- Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study.Frontiers in oncology · 2026Article
- Small-molecule control of CAR T cells.Nature reviews. Chemistry · 2025Review
- Chimeric antigen receptor T cell immunotherapy‑associated hemophagocytic lymphohistiocytosis: Pathogenesis, clinical manifestation, diagnosis and management compared with cytokine release syndrome (Review).Molecular medicine reports · 2025Review
- [Management of side effects of CAR T cells].Innere Medizin (Heidelberg, Germany) · 2025Review
- Venous Thromboembolic Events in Cancer Immunotherapy: A Narrative Review.Journal of clinical medicine · 2025Review
- Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS).Hematology/oncology clinics of North America · 2025Review
- T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS.Cancers · 2025Review
- Pancytopenia With Subsequent Diagnosis of Hemophagocytic Lymphohistiocytosis in a Middle-Aged Male.Case reports in oncological medicine · 2025Article
- Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Arushi KhuranaDivision of Hematology Mayo Clinic, Rochester, MN, USA.
Allison C RosenthalDivision of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Razan MohtyDivision of Hematology Oncology and Blood and Bone Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-0189-8233
Mamatha GaddamDivision of Hematology Mayo Clinic, Rochester, MN, USA.
Radhika BansalDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-0964-098X
Matthew A HathcockDivision of Hematology Mayo Clinic, Rochester, MN, USA.
Adrienne N NedvedDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Urshila DuraniDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1860-2424
Madiha IqbalDivision of Hematology Oncology and Blood and Bone Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0001-6752-5440
Yucai WangDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1576-8341
Jonas PaludoDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7350-5531
J C VillasboasDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-2907-0809
David DingliDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-7477-3004
Taxiarchis KourelisDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8573-9434
Nelson LeungDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5651-1411
Hassan AlkhateebDivision of Hematology Mayo Clinic, Rochester, MN, USA.
Michael W RuffDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Alice Gallo de MoraesDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Paschalis VergidisDivision of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.
Joerg HerrmannDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-6675-4559
Saad S KenderianDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-2767-3830
N Nora BennaniDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8358-5953
Patrick B JohnstonDivision of Hematology Mayo Clinic, Rochester, MN, USA.
Stephen M AnsellDivision of Hematology Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1244-6758
Yi LinDivision of Hematology Mayo Clinic, Rochester, MN, USA. Lin.Yi@mayo.edu.ORCID 0000-0002-1556-6416
Funding
Intravenous VSV virotherapy in lymphomaR01CA262613 · NCI · MAYO CLINIC ROCHESTER · PI BENNANI, NABILA NORA, PENG, KAH-WHYE · 2023 to 2025
$1.8MNCI NIH HHS R01 CA262613
Abstract
PubMed holds no abstract for this paper.
Indexed as
Immunotherapy, AdoptiveLymphohistiocytosis, HemophagocyticReceptors, Chimeric AntigenAdolescentAdultChildChild, PreschoolDisease ManagementFemaleHumansInfantMaleMiddle AgedTreatment OutcomeReceptors, Chimeric Antigen
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.